Literature DB >> 27173930

Epigenetics and Genetics of Viral Latency.

Paul M Lieberman1.   

Abstract

Viral latency can be considered a metastable, nonproductive infection state that is capable of subsequent reactivation to repeat the infection cycle. Viral latent infections have numerous associated pathologies, including cancer, birth defects, neuropathy, cardiovascular disease, chronic inflammation, and immunological dysfunctions. The mechanisms controlling the establishment, maintenance, and reactivation from latency are complex and diversified among virus families, species, and strains. Yet, as examined in this review, common properties of latent viral infections can be defined. Eradicating latent virus has become an important but elusive challenge and will require a more complete understanding of the mechanisms controlling these processes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA virus; epigenetics; genetics; herpesvirus; latency; reactivation; virus

Mesh:

Year:  2016        PMID: 27173930      PMCID: PMC5166714          DOI: 10.1016/j.chom.2016.04.008

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  135 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.

Authors:  Jianjiang Ye; Lyndle Gradoville; Derek Daigle; George Miller
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

3.  Pathogenetic mechansims of recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

4.  HSV Latency In Vitro : In Situ Hybridization Methods.

Authors:  C L Wilcox; R L Smith
Journal:  Methods Mol Med       Date:  1998

5.  Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency.

Authors:  Qingsong Qin; Rhiannon R Penkert; Robert F Kalejta
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

Review 6.  Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies.

Authors:  Thomas M Kristie
Journal:  Virology       Date:  2015-02-18       Impact factor: 3.616

7.  A primary neuron culture system for the study of herpes simplex virus latency and reactivation.

Authors:  Mariko Kobayashi; Ju-Youn Kim; Vladimir Camarena; Pamela C Roehm; Moses V Chao; Angus C Wilson; Ian Mohr
Journal:  J Vis Exp       Date:  2012-04-02       Impact factor: 1.355

8.  Disruption of HDAC/CoREST/REST repressor by dnREST reduces genome silencing and increases virulence of herpes simplex virus.

Authors:  Te Du; Guoying Zhou; Shaniya Khan; Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

9.  Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Future Virol       Date:  2012-09-01       Impact factor: 1.831

10.  Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein.

Authors:  Song Hee Lee; Emily R Albright; Jeong-Hee Lee; Derek Jacobs; Robert F Kalejta
Journal:  Sci Adv       Date:  2015-11-27       Impact factor: 14.136

View more
  61 in total

1.  Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma.

Authors:  Atsushi Okabe; Kie Kyon Huang; Keisuke Matsusaka; Masaki Fukuyo; Manjie Xing; Xuewen Ong; Takayuki Hoshii; Genki Usui; Motoaki Seki; Yasunobu Mano; Bahityar Rahmutulla; Teru Kanda; Takayoshi Suzuki; Sun Young Rha; Tetsuo Ushiku; Masashi Fukayama; Patrick Tan; Atsushi Kaneda
Journal:  Nat Genet       Date:  2020-07-27       Impact factor: 38.330

2.  Transcriptional Elongation of HSV Immediate Early Genes by the Super Elongation Complex Drives Lytic Infection and Reactivation from Latency.

Authors:  Roberto Alfonso-Dunn; Anne-Marie W Turner; Pierre M Jean Beltran; Jesse H Arbuckle; Hanna G Budayeva; Ileana M Cristea; Thomas M Kristie
Journal:  Cell Host Microbe       Date:  2017-04-12       Impact factor: 21.023

Review 3.  Emerging Proviral Roles of Caspases during Lytic Replication of Gammaherpesviruses.

Authors:  Tate Tabtieng; Marta M Gaglia
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 4.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 5.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

Review 6.  Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.

Authors:  Marni S Crow; Krystal K Lum; Xinlei Sheng; Bokai Song; Ileana M Cristea
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

Review 7.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

Review 8.  Hitchhiking of Viral Genomes on Cellular Chromosomes.

Authors:  Tami L Coursey; Alison A McBride
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

9.  Probabilistic control of HIV latency and transactivation by the Tat gene circuit.

Authors:  Youfang Cao; Xue Lei; Ruy M Ribeiro; Alan S Perelson; Jie Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-19       Impact factor: 11.205

10.  Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy.

Authors:  Tanner Dalton; Ekaterina Doubrovina; Dmitry Pankov; Raymond Reynolds; Hanna Scholze; Annamalai Selvakumar; Teresa Vizconde; Bhumesh Savalia; Vadim Dyomin; Christoph Weigel; Christopher C Oakes; Alicia Alonso; Olivier Elemento; Heng Pan; Jude M Phillip; Richard J O'Reilly; Benjamin E Gewurz; Ethel Cesarman; Lisa Giulino-Roth
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.